Novoheart Holdings Inc. Banner Image

Novoheart Holdings Inc.

  • Ticker NVH
    Exchange TSX-V More
  • Industry Biotechnology More
  • Sector Healthcare More
Novoheart Holdings Inc. Logo Image
  • 11-50 Employees
  • Based in Irvine, California
Novoheart (TSXV: NVH)(FWB: 3NH) is a global stem cell biotechnology company pioneering an array of next-generation human heart tissue prototypes. It is the first and only company in the world to have engineered miniature living human heart pumps that can revolutionize drug discovery, helping to save time and money for developing new therapeutics. Also known as 'human heart-in-a-jar'​More;, Novoheart’s bio-artificial human heart constructs are created using state-of-the-art and proprietary stem cell and bioengineering approaches and are utilized by global pharmaceutical and biotech companies for accurate preclinical testing as to the effectiveness and safety of new drugs, maximizing the successes in drug discovery whilst minimizing costs and harm caused to patients. Novoheart currently has corporate offices and laboratories in the United States, Canada, and Hong Kong.
4.8 / 5.0 (77)

Novoheart Holdings Inc. reports have an aggregate usefulness score of 4.8 based on 77 reviews.

Novoheart Holdings Inc.

Most Recent Annual Report

Novoheart Holdings Inc.
MOST RECENT 2019 Annual Report

Older/Archived Annual Reports

Novoheart Holdings Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!